# A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

> **NCT06200467** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 110 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **COMBINATION_PRODUCT:** BI 456906
- **COMBINATION_PRODUCT:** Placebo to BI 456906
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo to moxifloxacin

## Key facts

- **NCT ID:** NCT06200467
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-13
- **Primary completion:** 2025-10-22
- **Final completion:** 2025-10-22
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06200467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06200467, "A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06200467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*